Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure

IMPORTANCE: In 2015, the US Food and Drug Administration approved 2 new medications for treatment of heart failure with reduced ejection fraction, sacubitril/valsartan and ivabradine. However, few national data are available examining their contemporary use and associated costs. OBJECTIVE: To evalua...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Cardiol
Main Authors: Sumarsono, Andrew, Vaduganathan, Muthiah, Ajufo, Ezimamaka, Navar, Ann Marie, Fonarow, Gregg C., Das, Sandeep R., Pandey, Ambarish
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6865331/
https://ncbi.nlm.nih.gov/pubmed/31738371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.4982
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares